These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6217149)

  • 41. Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus.
    Filaci G; Bacilieri S; Fravega M; Monetti M; Contini P; Ghio M; Setti M; Puppo F; Indiveri F
    J Immunol; 2001 May; 166(10):6452-7. PubMed ID: 11342672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [T-suppressor functional activity in systemic lupus erythematosus and chronic glomerulonephritis].
    Gordovskaia NB; Denisov VN; Krasnova TN
    Ter Arkh; 1982; 54(7):29-32. PubMed ID: 6215736
    [No Abstract]   [Full Text] [Related]  

  • 43. Functional properties of CD8 positive lymphocyte subsets in systemic lupus erythematosus.
    Horwitz DA; Linker-Israeli M; Gray JD; Lemoine C
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():49-52. PubMed ID: 2956420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pregnancy Associated with Systemic Lupus Erythematosus: Immune Tolerance in Pregnancy and Its Deficiency in Systemic Lupus Erythematosus--An Immunological Dilemma.
    Gluhovschi C; Gluhovschi G; Petrica L; Velciov S; Gluhovschi A
    J Immunol Res; 2015; 2015():241547. PubMed ID: 26090485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leptin levels in patients with systemic lupus erythematosus inversely correlate with regulatory T cell frequency.
    Wang X; Qiao Y; Yang L; Song S; Han Y; Tian Y; Ding M; Jin H; Shao F; Liu A
    Lupus; 2017 Nov; 26(13):1401-1406. PubMed ID: 28409523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppressor T cell dysfunction and depressed immunoglobulin production by B cells in vitro in patients with SLE.
    Nishinarita S; Takizawa I; Hirai H; Morita K; Amaki I
    J Rheumatol; 1981; 8(1):19-30. PubMed ID: 6452522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Con A suppressor cell assay: a further characterization.
    Meroni PL; Balestrieri G; Barcellini W; DeBartolo G; Fenini G; Tincani A; Zanussi C
    J Clin Lab Immunol; 1983 Mar; 10(3):159-63. PubMed ID: 6221109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppressor cells assayed by three different methods in patients with chronic active hepatitis and systemic lupus erythematosus.
    Coovadia HM; MacKay IR; d'Apice AJ
    Clin Immunol Immunopathol; 1981 Feb; 18(2):268-75. PubMed ID: 6451342
    [No Abstract]   [Full Text] [Related]  

  • 50. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.
    Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y
    J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T-regulatory cells in systemic lupus erythematosus.
    La Cava A
    Lupus; 2008 May; 17(5):421-5. PubMed ID: 18490420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The dysfunction of human peripheral blood dendritic cells on concanavalin A-induced T cell responses in patients with systemic lupus erythematosus].
    Katagiri T
    Arerugi; 1992 Jun; 41(6):693-8. PubMed ID: 1444821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppressor cell function is preserved in pemphigus and pemphigoid.
    King AJ; Schwartz SA; Lopatin D; Voorhees JJ; Diaz LA
    J Invest Dermatol; 1982 Sep; 79(3):183-5. PubMed ID: 6213723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulatory T cells in systemic lupus erythematosus.
    Ohl K; Tenbrock K
    Eur J Immunol; 2015 Feb; 45(2):344-55. PubMed ID: 25378177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of FOXP3
    Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
    Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in immunoregulatory T cell circuits between diphenylhydantoin-related and spontaneously occurring systemic lupus erythematosus.
    Alarcón-Segovia D; Palacios R
    Arthritis Rheum; 1981 Aug; 24(8):1086-92. PubMed ID: 6456725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [No correlation between suppressor cell function and disease activity in natural history studies of patients with systemic lupus erythematosus].
    Rautenstrauch H; Frank F; Saal JG
    Z Rheumatol; 1985; 44(3):133-6. PubMed ID: 2932868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of La(SSB) on PWM-induced immunoglobulin synthesis by anti-La(SSB) positive SLE patients and healthy controls.
    Smith G; Morrison CA; Maddison PJ
    Clin Exp Immunol; 1987 Jun; 68(3):552-61. PubMed ID: 2958189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of lymphocytes that suppress IL-2 production in systemic lupus erythematosus.
    Linker-Israeli M; Gray JD; Quismorio FP; Horwitz DA
    Clin Exp Immunol; 1988 Aug; 73(2):236-41. PubMed ID: 2972425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppressor cell defect in SLE: relationship to native DNA binding.
    Krakauer RS; Clough JD; Alexander T; Sundeen J; Sauder DN
    Clin Exp Immunol; 1980 Apr; 40(1):72-6. PubMed ID: 6446432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.